Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian G Cannell

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|July 7, 2010
Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?Ian G Cannell, Martin Bushell
Critical Care Medicine|June 21, 2011
Salvaging the septic heart through targeting the interleukin-6/p38 mitogen-activated protein kinase signaling networkIan G Cannell, Michael B Yaffe
Biochemical Society Transactions|November 22, 2008
How do microRNAs regulate gene expression?Ian G Cannell, Yi Wen Kong, Martin Bushell
Cell Cycle (Georgetown, Tex.)|December 22, 2010
Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response?H Christian Reinhardt, Ian G Cannell, Sandra Morandell, et al.
Elife|December 16, 2022
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapiesSophia A Wild, Ian G Cannell, Ashley Nicholls, et al.
Molecular Cell|February 19, 2011
The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesisTheresia R Kress, Ian G Cannell, Arjan B Brenkman, et al.
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.
British Journal of Cancer|June 20, 2024
The in vitro dynamics of pseudo-vascular network formationMariam-Eleni Oraiopoulou, Dominique-Laurent Couturier, Ellie V Bunce, et al.
Cancer Cell|November 26, 2015
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.
Cancer Cell|August 28, 2017
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|July 7, 2010
Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?Ian G Cannell, Martin Bushell
Critical Care Medicine|June 21, 2011
Salvaging the septic heart through targeting the interleukin-6/p38 mitogen-activated protein kinase signaling networkIan G Cannell, Michael B Yaffe
Biochemical Society Transactions|November 22, 2008
How do microRNAs regulate gene expression?Ian G Cannell, Yi Wen Kong, Martin Bushell
Cell Cycle (Georgetown, Tex.)|December 22, 2010
Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response?H Christian Reinhardt, Ian G Cannell, Sandra Morandell, et al.
Elife|December 16, 2022
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapiesSophia A Wild, Ian G Cannell, Ashley Nicholls, et al.
Molecular Cell|February 19, 2011
The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesisTheresia R Kress, Ian G Cannell, Arjan B Brenkman, et al.
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.
British Journal of Cancer|June 20, 2024
The in vitro dynamics of pseudo-vascular network formationMariam-Eleni Oraiopoulou, Dominique-Laurent Couturier, Ellie V Bunce, et al.
Cancer Cell|November 26, 2015
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.
Cancer Cell|August 28, 2017
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.
Pageof 2